Format

Send to

Choose Destination
Front Immunol. 2019 Feb 25;10:303. doi: 10.3389/fimmu.2019.00303. eCollection 2019.

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.

Author information

1
Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
2
Department of Neurology, Columbia University Irving Medical Center, New York, NY, United States.
3
Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, United States.
4
Department of Medicine, University of California, San Diego, La Jolla, CA, United States.
5
Department of Pharmacology, Columbia University Irving Medical Center, New York, NY, United States.
6
Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, United States.

Abstract

Evidence from a variety of studies implicates a role for the adaptive immune system in Parkinson's disease (PD). Similar to multiple sclerosis (MS) patients who display a high number of T cells in the brain attacking oligodendrocytes, PD patients show higher numbers of T cells in the ventral midbrain than healthy, age-matched controls. Mouse models of the disease also show the presence of T cells in the brain. The role of these infiltrating T cells in the propagation of disease is controversial; however, recent studies indicate that they may be autoreactive in nature, recognizing disease-altered self-proteins as foreign antigens. T cells of PD patients can generate an autoimmune response to α-synuclein, a protein that is aggregated in PD. α-Synuclein and other proteins are post-translationally modified in an environment in which protein processing is altered, possibly leading to the generation of neo-epitopes, or self-peptides that have not been identified by the host immune system as non-foreign. Infiltrating T cells may also be responding to such modified proteins. Genome-wide association studies (GWAS) have shown associations of PD with haplotypes of major histocompatibility complex (MHC) class II genes, and a polymorphism in a non-coding region that may increase MHC class II in PD patients. We speculate that the inflammation observed in PD may play both pathogenic and protective roles. Future studies on the adaptive immune system in neurodegenerative disorders may elucidate steps in disease pathogenesis and assist with the development of both biomarkers and treatments.

KEYWORDS:

Parkinson's disease; T cells; adaptive immune system; autoimmunity; blood-brain barrier; neuroinflammation; α-synuclein

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center